Skip to content

Elite Pharmaceuticals Inc

ELTP· OTCCore metricsCIK 1053369

Pharmaceutical preparations552 peers

Close
Jul 1, 2026
Market cap
$387.77M
1.08B shares
Filings
1,015
$40.08M
Q2 2027+77.1% FY26 yoy
$17.32M
Q2 2027N/M FY26 yoy
$9.93M
Q2 2027+150.6% FY26 yoy
$5.45M
Q2 2027derived+291.4% FY26 yoy
$0.01
Q2 2027
$35.34M
Q2 2027+157.2% FY26 yoy
$387.77M
6.4×
2.7×
3.2×
2.25%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.3633.33%$0.18since Aug 5, 2025
Jul 1, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$148.87MFY 2026
$148.87M0FY 2015FY 2020FY 2026
PeriodEndedValueKindSource trail
FY 20262026-03-31$148,870,119reported
FY 20252025-03-31$84,043,929reported
FY 20242024-03-31$56,625,128reported
FY 20232023-03-31$34,155,114reported
FY 20222022-03-31$32,262,117reported
FY 20212021-03-31$25,380,749reported
FY 20202020-03-31$17,994,639reported
FY 20192019-03-31$7,568,508reported
FY 20182018-03-31$7,458,711reported
FY 20172017-03-31$9,637,715reported
FY 20162016-03-31$12,498,332reported
FY 20152015-03-31$5,015,246reported

Segments

Revenue by Segments, FY2020 to FY2025FY2020ANDA · FY2020 · $16.99MNDA · FY2020 · $1.00MFY2021ANDA · FY2021 · $25.21MNDA · FY2021 · $166.17KFY2023FY2024FY2025
LineFY2025ShareChange
New Drug Applications$0.00——
ANDA———
NDA———
Total$84.04M

From the 10-K filed Jun 30, 2025ELTP

Pharmaceutical preparations

Elite Pharmaceuticals Inc is the 96th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR